Q3 EARNINGS: LabCorp solid
This article was originally published in Clinica
Executive Summary
Laboratory Corporation of America (LabCorp) had a solid third-quarter, according to Goldman Sachs’ Isaac Ro, again beating analyst predictions. Sales of $1.55bn grew 6% year-on-year and were above consensus of $1.50bn; while adjusted earnings of $1.80 per share equalled Q3 2013 and exceeded analyst expectations of $1.75 per share.